Pharmaceutical immunoglobulin G impairs anti-carcinoma activity of oxaliplatin in colon cancer cells

BACKGROUND: Recent evidence proves that intravenous human immunoglobulin G (IgG) can impair cancer cell viability. However, no study evaluated whether IgG application benefits cancer patients receiving chemotherapeutics. METHODS: Influence of pharmaceutical-grade human IgG on the viability of a seri...

Descripción completa

Detalles Bibliográficos
Autores principales: Shang, Yuru, Zhang, Xianbin, Lu, Lili, Jiang, Ke, Krohn, Mathias, Matschos, Stephanie, Mullins, Christina Susanne, Vollmar, Brigitte, Zechner, Dietmar, Gong, Peng, Linnebacher, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039037/
https://www.ncbi.nlm.nih.gov/pubmed/33558709
http://dx.doi.org/10.1038/s41416-021-01272-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039037/
https://www.ncbi.nlm.nih.gov/pubmed/33558709
http://dx.doi.org/10.1038/s41416-021-01272-6

Ejemplares similares